Personalized treatment with PARP inhibitors in advanced urothelial carcinoma: a case report and literature review

Bladder cancer (BC) poses a significant health challenge, particularly in metastatic cases, where the prognosis is unfavorable and therapeutic options are limited. Poly ADP-ribose polymerase (PARP) inhibitors have gained approval for use in various cancer types, but their application in BC remains c...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Therapeutic advances in medical oncology 2024, Vol.16, p.17588359241245283-17588359241245283
Hauptverfasser:	Abbas, Noura, Chehade, Laudy, Shamseddine, Ali
Format:	Report
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!